A Bedi

3.0k total citations
16 papers, 2.1k citations indexed

About

A Bedi is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, A Bedi has authored 16 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in A Bedi's work include Chronic Myeloid Leukemia Treatments (6 papers), Acute Lymphoblastic Leukemia research (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). A Bedi is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Acute Lymphoblastic Leukemia research (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). A Bedi collaborates with scholars based in United States, South Korea and Ethiopia. A Bedi's co-authors include James Barber, RJ Jones, BA Zehnbauer, SJ Sharkis, Gauri C. Bedi, Rajani Ravi, Ephraim J. Fuchs, Richard J. Jones, Barbara A. Zehnbauer and Pankaj J. Pasricha and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

A Bedi

16 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Bedi United States 14 897 895 756 389 331 16 2.1k
Wendy Schober United States 34 729 0.8× 1.8k 2.0× 751 1.0× 381 1.0× 355 1.1× 64 3.0k
Chie Nishioka Japan 29 509 0.6× 1.1k 1.3× 718 0.9× 198 0.5× 214 0.6× 63 2.1k
Utz Krug Germany 25 432 0.5× 1.1k 1.2× 980 1.3× 282 0.7× 212 0.6× 82 2.0k
N Feller Netherlands 21 1.2k 1.4× 975 1.1× 1.1k 1.4× 235 0.6× 183 0.6× 56 2.5k
Hong Mu United States 24 362 0.4× 980 1.1× 642 0.8× 237 0.6× 159 0.5× 67 1.7k
C. Darrell Jennings United States 20 299 0.3× 450 0.5× 707 0.9× 257 0.7× 98 0.3× 58 1.8k
Vivian Ruvolo United States 36 1.6k 1.7× 2.9k 3.2× 1.4k 1.9× 460 1.2× 448 1.4× 153 4.7k
Runqing Lu United States 23 444 0.5× 759 0.8× 193 0.3× 206 0.5× 233 0.7× 36 2.0k
F Takaku Japan 20 498 0.6× 639 0.7× 528 0.7× 133 0.3× 155 0.5× 59 1.9k
Sixuan Qian China 25 321 0.4× 754 0.8× 496 0.7× 226 0.6× 269 0.8× 154 2.1k

Countries citing papers authored by A Bedi

Since Specialization
Citations

This map shows the geographic impact of A Bedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Bedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Bedi more than expected).

Fields of papers citing papers by A Bedi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Bedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Bedi. The network helps show where A Bedi may publish in the future.

Co-authorship network of co-authors of A Bedi

This figure shows the co-authorship network connecting the top 25 collaborators of A Bedi. A scholar is included among the top collaborators of A Bedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Bedi. A Bedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Izumchenko, Eugene, et al.. (2016). Patient‐derived xenografts as tools in pharmaceutical development. Clinical Pharmacology & Therapeutics. 99(6). 612–621. 44 indexed citations
2.
Niu, Gang, Kenneth H. Shain, Melinda Huang, et al.. (2001). Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest.. PubMed. 61(8). 3276–80. 110 indexed citations
3.
Bedi, A & Bijoyesh Mookerjee. (1998). Biological significance and molecular mechanisms of p53-induced apoptosis. APOPTOSIS. 3(4). 237–244. 13 indexed citations
4.
Ravi, Rajani, Bijoyesh Mookerjee, Yvette van Hensbergen, et al.. (1998). p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300.. PubMed. 58(20). 4531–6. 139 indexed citations
5.
Ravi, Rajani, A Bedi, & Ephraim J. Fuchs. (1998). CD95 (Fas)-induced caspase-mediated proteolysis of NF-kappaB.. PubMed. 58(5). 882–6. 105 indexed citations
6.
Sharkis, Saul J., et al.. (1996). Requirement of p34cdc2 kinase for apoptosis mediated by the Fas/APO-1 receptor and interleukin 1beta-converting enzyme-related proteases.. PubMed. 56(20). 4551–5. 53 indexed citations
7.
Bedi, A, et al.. (1996). Are growth factors leukemogenic?. PubMed. 10(1). 175–7. 19 indexed citations
8.
Pasricha, P. J., A Bedi, Asif Rashid, et al.. (1995). Inhibition of apoptosis in familial adenomatous polyposis (FAP) and its modification by sulindac. Gastroenterology. 108(4). A523–A523. 2 indexed citations
9.
Bedi, A, Carole B. Miller, Steven N. Goodman, et al.. (1995). Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation.. Journal of Clinical Oncology. 13(5). 1103–1109. 207 indexed citations
11.
Fuchs, Ephraim J., A Bedi, RJ Jones, & A. D. Hess. (1995). Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis.. PubMed. 55(3). 463–6. 45 indexed citations
12.
Bedi, A, Pankaj J. Pasricha, Adil Akhtar, et al.. (1995). Inhibition of apoptosis during development of colorectal cancer.. PubMed. 55(9). 1811–6. 485 indexed citations
13.
Bedi, A, BA Zehnbauer, James Barber, SJ Sharkis, & RJ Jones. (1994). Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood. 83(8). 2038–2044. 425 indexed citations
14.
Bedi, A, BA Zehnbauer, James Barber, SJ Sharkis, & RJ Jones. (1994). Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood. 83(8). 2038–2044. 54 indexed citations
15.
Bedi, A, BA Zehnbauer, MI Collector, et al.. (1993). BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood. 81(11). 2898–2902. 10 indexed citations
16.
Bedi, A, BA Zehnbauer, MI Collector, et al.. (1993). BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood. 81(11). 2898–2902. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026